Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
UBS
Colorcon
Chinese Patent Office
Federal Trade Commission
US Department of Justice
McKesson
Merck

Generated: May 24, 2018

DrugPatentWatch Database Preview

CENTRAX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Centrax patents expire, and what generic alternatives are available?

Centrax is a drug marketed by Parke Davis and is included in two NDAs.

The generic ingredient in CENTRAX is prazepam. There are four drug master file entries for this compound. Additional details are available on the prazepam profile page.
Summary for CENTRAX
Drug patent expirations by year for CENTRAX
Medical Subject Heading (MeSH) Categories for CENTRAX
Synonyms for CENTRAX
1-(cyclopropylmethyl)-5-phenyl-7-chloro-1h-1,4-benzodiazepin-2(3h)-one
2955-38-6
2H-1, 1,3-dihydro-7-chloro-1-(cyclopropylmethyl)-5-phenyl-
2H-1, 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-
2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-CHLORO-1-(CYCLOPROPYLMETHYL)-5-PHENYL-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-
7-Chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-Chloro-1-(cyclopropylmethyl)-1,4-benzodiazepin-2-one
7-Chloro-1-(cyclopropylmethyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Chloro-1-(cyclopropylmethyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #
7-chloro-1-(cyclopropylmethyl)-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one
7-Chloro-1-cyclopropylmethyl-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one
9-chloro-2-(cyclopropylmethyl)-6-phenyl-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen- 3-one
AC1L1J6K
BRN 0895797
C-19823
C07366
C19H17ClN2O
CAS-2955-38-6
CC-33902
Centrax (TN)
CHEBI:8362
CHEMBL969
CTK6H1723
D00470
D0G3AQ
DB01588
DEA No. 2764
Demetrin
Demetrin (TN)
DSSTox_CID_1181
DSSTox_GSID_21181
DSSTox_RID_75994
DTXSID4021181
EINECS 220-975-8
FT-0603623
GTPL7275
HE062078
HE332636
K-373
LS-7667
Lysanxia
Lysanxia (TN)
MLS003899231
Mono Demetrin (TN)
MWQCHHACWWAQLJ-UHFFFAOYSA-N
NCGC00168256-01
NCGC00168256-02
NCGC00257630-01
NSC 277179
NSC-277179
NSC277179
Pozapam (TN)
Prasepine (TN)
Prazeene
Prazene
Prazene (TN)
prazepam
Prazepam (JP15/USAN/INN)
Prazepam (JP17/USAN/INN)
Prazepam [USAN:INN:BAN:JAN]
Prazepam [USAN:USP:INN:BAN:JAN]
Prazepam 0.1 mg/ml in Methanol
Prazepam 1.0 mg/ml in Methanol
PRAZEPAM--DEA SCHEDULE IV ITEM
Prazepam, European Pharmacopoeia (EP) Reference Standard
Prazepam, United States Pharmacopeia (USP) Reference Standard
Prazepamum
Prazepamum [INN-Latin]
Q30VCC064M
Reapam (TN)
SCHEMBL78272
Sedapran
Settima
SMR000058725
Tox21_112615
Tox21_200076
Trepidan
Trepidan (TN)
UNII-Q30VCC064M
Verstran
W 4020
W-4020
WLN: T67 GNV JN IHJ CG KR& G1- AL3TJ
ZINC1971

US Patents and Regulatory Information for CENTRAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CENTRAX prazepam CAPSULE;ORAL 018144-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis CENTRAX prazepam TABLET;ORAL 017415-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis CENTRAX prazepam CAPSULE;ORAL 018144-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis CENTRAX prazepam CAPSULE;ORAL 018144-003 May 10, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Teva
Johnson and Johnson
US Department of Justice
Healthtrust
Chinese Patent Office
Cantor Fitzgerald
Boehringer Ingelheim
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.